Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes

Growth Metrics

Medinotec (MDNC) Shares Issued (2022 - 2023)

Medinotec filings provide 2 years of Shares Issued readings, the most recent being -$169375.0 for Q1 2023.

On a quarterly basis, Shares Issued fell 1793.75% to -$169375.0 in Q1 2023 year-over-year; TTM through Feb 2023 was $3.3 million, a N/A change, with the full-year FY2023 number at $3.3 million, changed N/A from a year prior.
Shares Issued hit -$169375.0 in Q1 2023 for Medinotec, down from $169375.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $3.3 million in Q2 2022 to a low of -$169375.0 in Q1 2023.